SelectScience InterviewsDrug Discovery & Development

The role of AI in proteomics

23 May 2024
Dora Wells
Clinical Content Editor
The role of AI in proteomics

Parag Mallick, Associate Professor at Stanford University and CoFounder and Chief Scientist at Nautilus Biotechnology, explores the transformative impact of artificial intelligence on proteomics. He discusses the significance of proteomics in life sciences and drug discovery, highlighting how machine learning at Nautilus enhances the analysis of complex protein data, surpassing traditional methods. Mallick also discusses the challenges of handling vast protein datasets and shares strategies for overcoming these hurdles. Additionally, he offers his vision for the future of proteomics in healthcare and draws intriguing parallels between his work in proteomics and his passion for magic, revealing how these interests uniquely complement each other.